These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 25075035)

  • 1. Targeting the Wnt/beta-catenin pathway in renal cell carcinoma.
    Von Schulz-Hausmann SA; Schmeel LC; Schmeel FC; Schmidt-Wolf IG
    Anticancer Res; 2014 Aug; 34(8):4101-8. PubMed ID: 25075035
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting the Wnt/beta-catenin pathway in multiple myeloma.
    Schmeel LC; Schmeel FC; Kim Y; Endo T; Lu D; Schmidt-Wolf IG
    Anticancer Res; 2013 Nov; 33(11):4719-26. PubMed ID: 24222106
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of Wnt inhibitors in pancreatic cancer.
    Wall I; Schmidt-Wolf IG
    Anticancer Res; 2014 Oct; 34(10):5375-80. PubMed ID: 25275031
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeting renal cancer with a combination of WNT inhibitors and a bi-functional peptide.
    Koller CM; Kim Y; Schmidt-Wolf IG
    Anticancer Res; 2013 Jun; 33(6):2435-40. PubMed ID: 23749892
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro efficacy of cinnarizine against lymphoma and multiple myeloma.
    Schmeel LC; Schmeel FC; Kim Y; Blaum-Feder S; Endo T; Schmidt-Wolf IG
    Anticancer Res; 2015 Feb; 35(2):835-41. PubMed ID: 25667464
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeting the Wnt/beta-catenin pathway with the antifungal agent ciclopirox olamine in a murine myeloma model.
    Kim Y; Schmidt M; Endo T; Lu D; Carson D; Schmidt-Wolf IG
    In Vivo; 2011; 25(6):887-93. PubMed ID: 22021681
    [TBL] [Abstract][Full Text] [Related]  

  • 7. WNT10A plays an oncogenic role in renal cell carcinoma by activating WNT/β-catenin pathway.
    Hsu RJ; Ho JY; Cha TL; Yu DS; Wu CL; Huang WP; Chu P; Chen YH; Chen JT; Yu CP
    PLoS One; 2012; 7(10):e47649. PubMed ID: 23094073
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pyrvinium Sensitizes Clear Cell Renal Cell Carcinoma Response to Chemotherapy Via Casein Kinase 1α-Dependent Inhibition of Wnt/β-Catenin.
    Cui L; Zhao J; Liu J
    Am J Med Sci; 2018 Mar; 355(3):274-280. PubMed ID: 29549930
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Brusatol enhances MEF2A expression to inhibit RCC progression through the Wnt signalling pathway in renal cell carcinoma.
    Wang T; Zhou Y; Bao H; Liu B; Wang M; Wang L; Pan T
    J Cell Mol Med; 2023 Dec; 27(23):3897-3910. PubMed ID: 37859585
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The human T-cell factor-4 gene splicing isoforms, Wnt signal pathway, and apoptosis in renal cell carcinoma.
    Shiina H; Igawa M; Breault J; Ribeiro-Filho L; Pookot D; Urakami S; Terashima M; Deguchi M; Yamanaka M; Shirai M; Kaneuchi M; Kane CJ; Dahiya R
    Clin Cancer Res; 2003 Jun; 9(6):2121-32. PubMed ID: 12796377
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reduced E-cadherin facilitates renal cell carcinoma progression by WNT/β-catenin signaling activation.
    Zhang X; Yang M; Shi H; Hu J; Wang Y; Sun Z; Xu S
    Oncotarget; 2017 Mar; 8(12):19566-19576. PubMed ID: 28223537
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of canonical WNT/β-catenin signaling is involved in leflunomide (LEF)-mediated cytotoxic effects on renal carcinoma cells.
    Chen Y; Huang Q; Zhou H; Wang Y; Hu X; Li T
    Oncotarget; 2016 Aug; 7(31):50401-50416. PubMed ID: 27391060
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rapamycin inhibits lung squamous cell carcinoma growth by downregulating glypican-3/Wnt/β-catenin signaling and autophagy.
    Bi Y; Jiang Y; Li X; Hou G; Li K
    J Cancer Res Clin Oncol; 2021 Feb; 147(2):499-505. PubMed ID: 33225417
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ethacrynic acid exhibits selective toxicity to chronic lymphocytic leukemia cells by inhibition of the Wnt/beta-catenin pathway.
    Lu D; Liu JX; Endo T; Zhou H; Yao S; Willert K; Schmidt-Wolf IG; Kipps TJ; Carson DA
    PLoS One; 2009 Dec; 4(12):e8294. PubMed ID: 20011538
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Porcupine Inhibitor LGK974 Downregulates the Wnt Signaling Pathway and Inhibits Clear Cell Renal Cell Carcinoma.
    Li J; Wu G; Xu Y; Li J; Ruan N; Chen Y; Zhang Q; Xia Q
    Biomed Res Int; 2020; 2020():2527643. PubMed ID: 32104684
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Silibinin inhibits epithelial‑mesenchymal transition of renal cell carcinoma through autophagy‑dependent Wnt/β‑catenin signaling.
    Fan Y; Hou T; Dan W; Liu T; Luan J; Liu B; Li L; Zeng J
    Int J Mol Med; 2020 May; 45(5):1341-1350. PubMed ID: 32323735
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interaction between Wnt/β-catenin signaling pathway and EMT pathway mediates the mechanism of sunitinib resistance in renal cell carcinoma.
    Cai F; Li J; Zhang Y; Huang S; Liu W; Zhuo W; Qiu C
    BMC Cancer; 2024 Feb; 24(1):175. PubMed ID: 38317072
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeting the canonical Wnt/β-catenin pathway in hematological malignancies.
    Ashihara E; Takada T; Maekawa T
    Cancer Sci; 2015 Jun; 106(6):665-671. PubMed ID: 25788321
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ANGPTL3 Overexpression Suppresses the Development of Oncogenic Properties in Renal Cell Carcinoma via the Wnt/
    Zhang YJ; Zhang L; Feng F; Cao QF
    Dis Markers; 2021; 2021():2863856. PubMed ID: 34484467
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A comprehensive analysis of Wnt/β-catenin signaling pathway-related genes and crosstalk pathways in the treatment of As
    Li YL; Jin YF; Liu XX; Li HJ
    Ren Fail; 2018 Nov; 40(1):331-339. PubMed ID: 29633893
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.